Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 23
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
Fludarabine, Busulfan, and Alemtuzumab Followed By Donor Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disease
Phase II, Phase I
BCM-H-19386
BCM-FAB, H 19386, NCT00625144
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies
Phase II, Phase I
CLBH589B2102
NCT00621244
Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies
Phase II, Phase I
8717
NCT00673114
2CDA With Rituximab in Hairy Cell Leukemia
Phase II
2004-0223
NCT00412594
Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
Phase II
SGL2003
NCT00421213
DepoCyt for Active Lymphomatous or Leukemic Meningitis
Phase II
9010
NCT00523939
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Phase II
11300A
NCT00683046
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
Phase II
NCI-09-C-0005
09-C-0005, NCI-P08372
Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes
Phase I
CYC682-05-04
NCT00380653
Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer
Phase I
MPC-2130-04-002
NCT00387153
1
2
3
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute